LEADER 05360nam 22007335 450 001 9910298214803321 005 20210218120530.0 010 $a3-319-66833-1 024 7 $a10.1007/978-3-319-66833-8 035 $a(CKB)4100000004243459 035 $a(DE-He213)978-3-319-66833-8 035 $a(MiAaPQ)EBC5390258 035 $a(PPN)227405390 035 $a(EXLCZ)994100000004243459 100 $a20180510d2018 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aLeading Pharmaceutical Innovation $eHow to Win the Life Science Race /$fby Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer 205 $a3rd ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (XV, 179 p. 41 illus., 3 illus. in color.) 311 $a3-319-66832-3 327 $aInnovation: Key to Success in the Pharmaceutical Industry -- The Industry Challenge: Who Would Want to Be in This Business?- The Science and Technology Challenge: How to Find New Drugs -- The Pipeline Challenge: How to Organize Innovation -- The Make-or-Buy Challenge: How to In- and Outsource Innovation -- The Open Innovation Challenge: How to Partner for Innovation -- The Internationalization Challenge: Where to Access Innovation -- Future Directions and Trends. 330 $aThis book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early-stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation. Health care innovation is possibly the greatest opportunity and challenge of our generation. This important book shows how pharmaceutical companies will continue to play an instrument role in making our lives better. Stefan Thomke, William Barclay Harding Professor of Business Administration, Harvard Business School Very comprehensive review and analysis of current challenges for the biopharmaceutical industry. To stay competitive in this new technology driven environment, the industry started to develop new partnership models to close the innovation gap and provide patients with the relevant healthcare toolkits at the convergence of pharmaceuticals, diagnostics and IT technologies. Very exciting times ahead well depicted in this book! Karima Boubekeur, VP Emerging Portfolio and Search & Evaluation, AstraZeneca Great. The 3rd edition is not only an update. It?s an outstandingly featured summary on the challenges of pharma innovation. Eckard von Keutz, SVP and Head of Early Development, Bayer Healthcare. 606 $aManagement 606 $aIndustrial management 606 $aPharmaceutical technology 606 $aPharmacy management 606 $aPharmacy 606 $aHealth care management 606 $aHealth services administration 606 $aHealth economics 606 $aInnovation/Technology Management$3https://scigraph.springernature.com/ontologies/product-market-codes/518000 606 $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010 606 $aPharmacoeconomics and Health Outcomes$3https://scigraph.springernature.com/ontologies/product-market-codes/H69020 606 $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008 606 $aHealth Care Management$3https://scigraph.springernature.com/ontologies/product-market-codes/527030 606 $aHealth Economics$3https://scigraph.springernature.com/ontologies/product-market-codes/W35000 615 0$aManagement. 615 0$aIndustrial management. 615 0$aPharmaceutical technology. 615 0$aPharmacy management. 615 0$aPharmacy. 615 0$aHealth care management. 615 0$aHealth services administration. 615 0$aHealth economics. 615 14$aInnovation/Technology Management. 615 24$aPharmaceutical Sciences/Technology. 615 24$aPharmacoeconomics and Health Outcomes. 615 24$aPharmacy. 615 24$aHealth Care Management. 615 24$aHealth Economics. 676 $a658.514 700 $aGassmann$b Oliver$4aut$4http://id.loc.gov/vocabulary/relators/aut$0147678 702 $aSchuhmacher$b Alexander$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $avon Zedtwitz$b Max$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aReepmeyer$b Gerrit$4aut$4http://id.loc.gov/vocabulary/relators/aut 906 $aBOOK 912 $a9910298214803321 996 $aLeading Pharmaceutical Innovation$92526800 997 $aUNINA